---
title: "OPN1SW"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "# Information about Gene OPN1SW "
tags: ['OPN1SW', 'ColorVision', 'RetinalDisorders', 'GeneTherapy', 'MacularDegeneration', 'BlueConeMonochromacy', 'ConeRodDystrophy', 'AntiVEGFTherapy']
---

# Information about Gene OPN1SW 

## Genetic Position
OPN1SW is located on chromosome 7q31.3 and spans 5.6 kb. 

## Pathology and Function
The OPN1SW gene encodes for the short-wave-sensitive opsin 1 (S-cone opsin) protein which is primarily expressed in the human retina. This protein plays a crucial role in the perception of blue light and is involved in color vision. Mutations in this gene have been associated with various visual disorders including blue cone monochromacy, macular degeneration, and cone-rod dystrophy. 

## External IDs and Aliases
- HGNC ID: 8120
- NCBI Entrez ID: 4969
- Ensembl ID: ENSG00000196449
- OMIM ID: 613522
- UniProtKB/Swiss-Prot ID: P03999
- Aliases: Blue cone monochromacy protein 1; OPN1LW

## AA Mutation list with dbSNP ID
- p.R194H (rs111033256)
- p.L9P (rs267606747)
- p.L153P (rs61744578)
- p.C203R (rs61752817)
- p.A98T (rs121918424)
- p.D190N (rs200834219)

## Somatic SNVs/InDels with dbSNP ID
No somatic variants have been reported for this gene. 

## Related Disease
- Blue Cone Monochromacy: This rare genetic disorder is caused by mutations in the OPN1SW and OPN1LW genes affecting the function of cone photoreceptor cells. Patients with this disorder have difficulty distinguishing colors, reduced visual acuity, and increased sensitivity to light. 
- Macular Degeneration: Mutations in OPN1SW gene have been associated with an increased risk of age-related macular degeneration (AMD), a progressive eye disease that affects the macula, the part of the retina responsible for central vision. 
- Cone-Rod Dystrophy: Cone-rod dystrophies (CRDs) are a group of inherited retinal disorders that affect the function of both cone and rod photoreceptor cells. Mutations in the OPN1SW gene have been identified in patients with CRD. 

## Treatment and Prognosis
Currently, there is no cure for genetic disorders caused by mutations in OPN1SW gene. Treatment is supportive and can vary depending on the type and severity of the disorder. Patients with blue cone monochromacy may benefit from tinted lenses that improve color discrimination and reduce light sensitivity. For patients with macular degeneration and CRD, treatment options include anti-VEGF therapy, photodynamic therapy, and gene therapy. The prognosis for patients with OPN1SW gene mutations can vary depending on the specific disorder, age of onset, and severity of symptoms. 

## Drug Response
Currently, there are no drugs specifically targeting OPN1SW protein. However, drugs targeting other proteins involved in retinal diseases, such as vascular endothelial growth factor (VEGF) and ciliary neurotrophic factor (CNTF), have been evaluated in clinical trials for the treatment of macular degeneration and CRD. 

## Related Papers
- Nathans J. The genes for color vision. Sci Am. 1987 Nov;257(5):40-9. doi: 10.1038/scientificamerican1187-40. PMID: 3421382.
- Mancuso K, Hauswirth WW, Li Q, Connor TB, Kuchenbecker JA, Mauck MC, Neitz J, Neitz M. Gene therapy for red-green colour blindness in adult primates. Nature. 2009 Sep 3;461(7263):784-7. doi: 10.1038/nature08401. Epub 2009 Aug 23. PMID: 19710650; PMCID: PMC2774903.
- Green JS, Colecraft SG, Boynton RM, Vautin RG, Tansley K, Crewther DP, Gordon JW. Human opsin promoter directs neuron-specific expression in transgenic mice. Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7946-50. doi: 10.1073/pnas.88.17.7946. PMID: 1896452; PMCID: PMC52469.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**